TDG insider Joel Reiss exercises 3,000 options, sells 3,000 shares
TransDigm (TDG) insider activity: Joel Reiss, listed as Co-Chief Operating Officer, reported transactions dated 09/22/2025.
Rhea-AI Filing Summary
TransDigm (TDG) insider activity: Joel Reiss, listed as Co-Chief Operating Officer, reported transactions dated 09/22/2025. He exercised a stock option covering 3,000 shares at an exercise price of $284.97 and simultaneously sold 3,000 common shares in multiple trades at weighted average prices reported in ranges of approximately $1,270.01 to $1,279.40 per share.
After these transactions Reiss beneficially owned 3,600 shares of common stock and continued to hold 50,000 stock options exercisable through 11/08/2027. The Form 4 was signed by an attorney-in-fact on 09/24/2025 and includes weighted-average price explanations for the sales.
Positive
- Detailed disclosure of exercise and multiple sales with weighted-average price ranges provided
- Timely reporting: transactions dated 09/22/2025 and Form 4 signed 09/24/2025
- Continued ownership of substantial options: 50,000 stock options remain outstanding
Negative
- Direct common stock ownership decreased to 3,600 shares after the reported sales
Insights
TL;DR: Executive exercised options then sold an equal number of shares; remaining direct ownership modest versus option holdings.
The filing shows a routine option exercise of 3,000 shares at $284.97 followed by the sale of those 3,000 shares across multiple executions at average prices within $1,270–$1,279 per share. Net direct common stock ownership fell to 3,600 shares while derivative holdings remain at 50,000 options expiring 11/08/2027. This is a standard liquidity transaction by an insider and does not, by itself, disclose company operational changes or new material information.
TL;DR: Disclosure complies with Section 16 reporting: exercise and contemporaneous sales are itemized with price ranges.
The Form 4 provides required detail: transaction codes, amounts, post-transaction beneficial ownership, and weighted-average sale-price explanations. The trades were reported promptly and signed by an authorized attorney-in-fact. No departures from standard disclosure practice are evident in the form's content.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option | 3,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 3,000 | $284.97 | $855K |
| Sale | Common Stock | 136 | $1,270.1465 | $173K |
| Sale | Common Stock | 122 | $1,271.3634 | $155K |
| Sale | Common Stock | 222 | $1,272.7116 | $283K |
| Sale | Common Stock | 120 | $1,274.2938 | $153K |
| Sale | Common Stock | 55 | $1,274.8564 | $70K |
| Sale | Common Stock | 1,288 | $1,276.0513 | $1.64M |
| Sale | Common Stock | 422 | $1,277.1839 | $539K |
| Sale | Common Stock | 635 | $1,279.1467 | $812K |
Footnotes (8)
- F1. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,270.0100 - $1,270.3300. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F2. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,271.2000 - $1,272.1500. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,272.2000 - $1,273.1900. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F4. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,273.7000 - $1,274.4125. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F5. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,274.7500 - $1,275.7400. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F6. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,275.7425 - $1,276.6800. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F7. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,276.8800 - $1,277.7025. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F8. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,279.0500 - $1,279.4000. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Joel Reiss (TDG) do on 09/22/2025?
Does Joel Reiss still hold options in TDG after the transactions?
Who signed the Form 4 and when?
AI-generated analysis. How Rhea-AI works. Not financial advice.